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Introduction: Haemophilia is related to several clinical and psychosocial challenges 
that have been associated with increased emotional distress. These may impact on 
disease adjustment and health outcomes, reinforcing the attention given to psycho-
social health of people with haemophilia (PWH), in the scope of optimal comprehen-
sive care.
Aim: To identify potentially modifiable factors associated with the presence of anxi-
ety and depression symptoms among adult PWH.
Methods: This was a cross- sectional observational study examining socio- 
demographic, clinical and psychosocial variables among 102 patients with haemo-
philia A or B who participated on a mail survey of haemophilia in Portugal.
Results: People with haemophilia revealing higher anxiety and depression symptoms 
were more likely to have had, in the previous year, more urgent hospital visits due to 
haemophilia, more bleeding episodes, more affected joints and pain, as well as worst 
levels of perceived functionality and quality of life. After controlling for demographic 
(age and education) and clinical (haemophilia severity and joint deterioration) varia-
bles in multivariate hierarchical logistic regression analyses, professional status 
(OR = 4.646, P = .004; OR = 3.333, P = .029) and pain interference (OR = 1.397, 
P = .011; OR = .1.347, P = .037) were significantly associated with both anxiety and 
depression symptoms. Additionally, physical activity (OR = 0.302, P = .024) and the 
perception of consequences underlying haemophilia (OR = 1.600, P = .012) also 
emerged as key factors significantly associated with depression symptoms.
Conclusion: Current findings increased knowledge on factors associated with anxi-
ety and depression among PWH. These highlight potential intervention targets, 
which are amenable to change through evidence- based tailored interventions aiming 
to decrease emotional distress, promote well- being and improving haemophilia- 
related health outcomes among these patients.
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1  | INTRODUC TION
Haemophilia is a rare genetic disorder associated with a pattern of 
spontaneous bleeding that is the hallmark of the disease.1 Factor 
replacement therapy remains the mainstay of treatment, aiming to 
increase coagulation factor levels, in order to prevent or to stop 
bleeds.2
Despite much improvement in treatment, people with hae-
mophilia (PWH) still face many important clinical challenges, such 
as demanding treatment regimens, severe acute pain related to 
haemarthrosis, debilitating haemophilic arthropathy or inhibitor 
development,2,3 which are associated with increased emotional 
distress.3-5
Beyond clinical manifestations, PWH also cope with challeng-
ing psychosocial issues,6 such as uncertainty, social restriction 
and unemployment, which have also been associated with higher 
emotional disturbance.4,5,7 As such, current guidelines for optimal 
haemophilia care establish psychosocial health promotion as a 
priority, along with the prevention of bleeds and management of 
complications.1 This is particularly relevant considering that medi-
cal treatments alone may not be sufficient to address some of the 
challenges faced by PWH.6 Moreover, high levels of distress have 
a detrimental impact on adherence to factor replacement therapy 
and disease management, potentially affecting haemophilia- related 
health outcomes.8,9 Given these associations, and regardless of 
whether emotional distress is a cause or a consequence of disease 
and treatment issues, a promising strategy for improving haemo-
philia outcomes would therefore be the effective management of 
emotional distress experienced by patients. A thorough psychoso-
cial assessment, including an appropriate anxiety and depression 
screening, is therefore warranted in haemophilia care, towards a 
more systemic approach and integrated care.8,10 Nevertheless, 
the screening of anxiety and depression in PWH has been either 
undifferentiated and overlapped or based on relatively unspecific 
evaluation of symptoms. This assessment often relies on general 
mental health dimensions assessed by quality of life question-
naires,7 which might hinder accurate diagnosis. Therefore, the use 
of specific standardized measures validated for anxiety/depression 
screening would be an essential step towards a more precise evalu-
ation of distress levels among PWH. Concurrently, it is also crucial 
to identify modifiable factors that are associated with anxiety and 
depression, in order to inform the development of tailored treat-
ments targeting these key outcomes. In this scope, the effective-
ness of psychological interventions is well established,11,12 with 
some reports suggesting the usefulness and cost- effectiveness of 
these interventions in the improvement of coping strategies and 
emotional well- being among PWH.13,14
This study aimed to investigate which potentially modifiable fac-
tors were associated with the presence of anxiety and depressive 
symptoms among adults with haemophilia. Ultimately, this contrib-
utes to uncover intervention targets that are amenable to change or 
to active management, and therefore suitable to inform the develop-
ment of tailored psychological interventions for PWH.
2  | MATERIAL S AND METHODS
2.1 | Design and participants
This study is part of a large cross- sectional observational study 
conducted among Portuguese PWH registered in the Portuguese 
Haemophilia Association (APH). According to the World Federation 
of Haemophilia, there is a reported prevalence of 703 PWH 
in Portugal (haemophilia A: 539; haemophilia B: 112; type un-
known:52).15 Of these, 500 PWH were reached by mail from 
October 2016 to May 2017 to complete a survey concerning socio- 
demographic, clinical and psychosocial characteristics of PWH, 
which was returned by 146 participants (29.2% return rate). More 
detailed information concerning survey procedure and patient re-
cruitment can be found elsewhere.16 From the 106 adults returning 
the survey, 4 were excluded due to missing data on the anxiety or 
depression measures, leaving 102 participants in the final sample. 
For the purposes of current study, wherein the focus is on emo-
tional distress, data concerning the assessments of anxiety and 
depression were retained to be analysed as the main outcome. 
Participants included in this study were males with haemophilia A 
or B of any severity and age over 18 years old. Ethical approval was 
obtained from the Ethical Committee at University of Minho and 
the Portuguese Data Protection Agency, and written informed con-
sent was obtained from all the participants. The study is registered 
at clinicaltrials.gov (NCT02870114).
2.2 | Data collection
Data were collected using the Portuguese versions of the following 
questionnaires. The tools that had not yet been adapted to European 
Portuguese (A36 Hemofilia- QoL and Haemophilia Activities List) un-
derwent a complete translation–back translation process followed 
by pilot testing, conducted by our team for the purposes of this 
investigation.
Socio-Demographic and Clinical Questionnaire: collects socio- 
demographic, clinical (eg bleeds and affected joints) and physical 
activity data. Participants were asked if they practiced some form of 
physical activity, either regularly or occasionally, and provided infor-
mation on the frequency and types of activities.
Pain Questionnaire: Information regarding pain was evaluated 
with single- questions asking about the presence of pain in the pre-
vious year, if it lasted over 3 months or occurred more than once a 
week (yes/no format); and about pain duration (in months). Intensity 
was assessed through a 0- 10 Numerical Rating Scale (NRS) (0 = no 
pain; 10 = worst imaginable pain) in six situations (eg bleeding ep-
isodes, using stairs, sitting or lying down). Interference score was 
based on the Brief Pain Inventory (BPI) interference subscale,17 ac-
cording to 7 dimensions rated on an 0- 10 NRS (0 = no interference; 
10 = completely interferes). An average total score is computed to 
reach intensity (α = 0.88) and interference (α = 0.91) global scores.
PROMIS® Depression and Anxiety short-forms18: measure symp-
toms of anxiety (α = 0.83) and depression (α = 0.92) with 4 items 
each. Scores range from 4 to 20, with higher scores indicating more 
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severe symptoms. A score of 8 has been proposed as the cut- off for 
clinically relevant symptoms in both scales.19
Illness Perception Questionnaire-Revised (IPQ-R)20: assesses per-
ceptions and beliefs about haemophilia through a psychometrically 
shortened 21- item version,21 considering seven subscales: timeline 
acute/chronic (α = 0.63), timeline cyclical (α = 0.70), consequences 
(α = 0.76), personal control (α = 0.52), treatment control (α = 0.42), 
illness coherence (α = 0.73) and emotional representation (α = 0.87). 
The scores for each dimension range between 3 and 15, with higher 
values translating more threatening illness perceptions, and no global 
score is computed for the IPQ- R. Due to missing data in all subscales, 
missing data patterns were examined using the Little’s MCAR test.22 
Using this statistical procedure, it was observed that all incomplete in-
formation (<3% of the entries in the dataset) were “missing completely 
at random” (MCAR; χ2(302) = 292.48, P = .642). As such, a Multiple 
Imputation (MI) method was used to calculate the missing data, based 
on the Expectation Maximization (EM) algorithm, which is considered 
an unbiased strategy to impute missing data information.23
A36 Hemofilia-QoL24: evaluates haemophilia- specific quality of 
life through 36 items. A percentile score can be computed (0- 100 
percentile) for the global scale (α = 0.96), with higher scores translat-
ing better quality of life.
Haemophilia Activities List (HAL)25: assesses patients’ self- 
perceived functionality, namely the difficulty in performing activ-
ities due to haemophilia through 42 items (α = 0.98), with global 
score ranging from 0 (worst functional status) to 100 (best functional 
status).
2.3 | Statistical analysis
Data analysis was conducted using the IBM SPSS® version 24 soft-
ware (Chicago, IL, USA) and the IBM SPSS® Amos version 24 for data 
imputation.
Descriptive statistics for continuous variables are presented 
as median and range, whereas categorical data are presented as 
numbers and percentages. Internal consistency of responses to the 
Portuguese versions of psychosocial questionnaires was assessed 
using Cronbach’s alpha.26
Given the aim of this paper of uncovering factors associated 
with the presence of anxiety/depression symptoms, the two pri-
mary outcomes were assessed as dichotomous variables: presence 
(PROMIS	≥	8)	 or	 absence	 (PROMIS	<	8)	 of	 significant	 anxiety	 and	
depression symptoms.19 Distribution of predictive data differed 
significantly from normality assumptions. Thus, Mann- Whitney (for 
continuous variables) and chi- square tests or the Fisher exact test 
(for nominal variables) were performed to compare groups. To deter-
mine the meaningfulness of the differences (practical significance), 
since statistical significance (P- value) is dependent on group size, the 
associated effect sizes were also computed. They were expressed as 
r score for continuous variables and Pearson’s phi (Φ) coefficient for 
nominal variables.
Finally, a set of predictive hierarchical multivariate logistic re-
gression models were conducted to analyse the factors associated 
with the presence of anxiety and depression symptoms. The vari-
ables selected for inclusion in the models were those which better 
distinguished between either the anxiety or the depression groups in 
univariate analysis, both in terms of statistical significance (P ≤	.001)	
and simultaneously showing at least a medium effect size (>0.30).27 
In addition, all the comparisons were adjusted for relevant socio- 
demographic and clinical variables: age, education, haemophilia se-
verity and number of affected joints.
Considering the potential shared variance among the indepen-
dent factors, and due to the small sample size, four different sub- 
models were considered for each distinctive outcome–anxiety and 
depression. The first model focused on the role of professional 
status, the second centred on physical activity practice, the third 
model explored the role of pain (intensity and interference) and, 
finally, the fourth model addressed illness perceptions (timeline 
cyclical, consequences and emotional representation related to 
haemophilia). Statistically significant results were considered for 
P < .05. Multicollinearity was analysed through the variance inflation 
factor value (VIF<2) and the tolerance coefficients (>0.60) for each 
variable.28
3  | RESULTS
3.1 | Association of emotional distress with clinical 
and psychosocial outcomes
In	the	present	sample,	significant	(PROMIS≥8)	anxiety	and	depres-
sion symptoms were found on 37 (36.3%) and 28 (27.5%) partici-
pants, respectively. Figure 1 (A- F) illustrates the differences among 
participants with and without significant anxiety/depression symp-
toms on key haemophilia- related clinical and psychosocial outcomes.
3.2 | Characteristics and differences 
between groups of patients with and without 
anxiety and depression
Table 1 shows that, for both anxiety and depression, participants 
who	revealed	significant	clinical	symptoms	(PROMIS	≥	8)	were	older	
than those without those symptoms (anxiety: P = .018, r = .260; 
depression: P = .04, r = .204) and were more often unemployed, re-
tired or on medical leave (anxiety: P < .001, Φ = 0.411; depression: 
P < .001, Φ = 0.357). Regarding physical activity, its practice was sig-
nificantly associated with less symptoms of both anxiety (P = .038, 
Φ = 0.206) and depression (P = .001, Φ = 0.324). The groups did not 
differ significantly in any of the other socio- demographic measures.
Table 1 reveals that those presenting either anxiety or depres-
sion were more likely to report bleeds (P = .019, Φ = 0.245; P = .006, 
Φ = 0.284; respectively) and urgent hospital visits due to haemo-
philia in the previous year (P = .005, Φ = 0.290; P = .012, Φ = 0.258; 
respectively), also indicating a higher number of affected joints 
(P < .001, r = .386; P < .001, r = .284; respectively). Pain was more 
often reported among participants presenting significant anxious 
(P = .004, Φ = 0.288) and depressive (P = .001, Φ = 0.317) symptoms 
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(Table 1), who also perceived it as more intense (anxiety: P < .001, 
r = .423; depression: P < .001, r = .476) and as having more interfer-
ence in their lives (anxiety: P < .001, r = .472; depression: P < .001, 
r = .457). Table 1 also indicates that a perception of symptoms un-
predictability (“timeline cyclical”) was more prominent among PWH 
presenting anxious (P = .001, r = .351) and depressive (P < .001, 
r = .380) symptoms, who also had more negative haemophilia- 
related consequences (anxiety: P < .001, r = .479; depression: 
P < .001, r = .588) and more negative emotional representations of 
the disease (anxiety: P < .001, r = .370; depression: P < .001, r = .41). 
Finally, both symptomatic groups reported worst levels of func-
tionality (anxiety: P < .001, r = .443; depression: P < .001, r = .443) 
and quality of life (anxiety: P < .001, r = .503; depression: P < .001, 
r = .408).
3.3 | Factors associated with the presence of 
anxiety and depressive symptoms
The results of the multivariate hierarchical logistic regression analy-
ses are presented on Table 2. Model 1 shows that those being un-
employed, retired or on medical leave were more likely to report 
both anxiety (OR = 4.646; P = .004) and depressive symptoms 
(OR = 3.333; P = .029). Model 2 reveals that PWH who practice any 
type of physical activity tend to report less depressive symptoms 
than those who are sedentary (OR = 0.302; P = .024). Regarding pain, 
Model 3 uncovers that increased levels of pain interference were 
significantly associated with the presence of anxiety (OR = 1.397; 
P = .011) and depressive (OR = 1.347; P = .037) symptoms among 
PWH. Focusing on illness perceptions, Model 4 evidences that a 
heightened perception of detrimental consequences related with 
haemophilia increases the likelihood of depressive symptomatology 
(OR = 1.600; P = .012). None of the IPQ- R subscales was associated 
with anxiety symptoms in the final multivariate model, despite their 
significant role in the previous univariate analysis.
4  | DISCUSSION
This study aimed to identify modifiable factors associated with 
anxiety and depression among PWH. The findings highlighted a 
considerable proportion of participants with significant symptoms, 
and the association of anxiety and depression with clinical and psy-
chosocial outcomes. It was also revealed that professional status, 
physical activity, pain interference and perception of haemophilia- 
related negative consequences were associated with increased 
symptomatology. This was, to the best of our knowledge, the first 
study with PWH specifically aiming to identify factors associated 
to anxiety and depression that can be targeted by psychological in-
terventions. In addition, the use of standardized scales for anxiety 
and depression screening was also a distinguishable feature of this 
investigation. Most studies in haemophilia field report anxiety/de-
pression levels based on mental health subscales of health- related 
quality of life questionnaires,29-32 on self- reports of presence of 
anxiety/depression,9,33 or on unstandardized questions developed 
F IGURE  1 Differences among participants with and without significant anxiety/depression symptoms on haemophilia- related outcomes
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TABLE  1 Sample characteristics and group comparisons between emotional distress groups (anxiety and depression) on socio- 







PROMIS < 8 
(N = 65)
PROMIS ≥8 
(N = 37) P
Effect 
size*
PROMIS < 8 
(N = 74)
PROMIS ≥ 8 
(N = 28) P
Effect 
size*
Age (y) 43 (18- 74) 40 (18- 69) 46 (21- 74) .018 0.260 41 (18- 69) 48 (21- 74) .040 0.204
Education
Primary school (1st- 4th 
grade)
6 (5.9%) 2 (3.1%) 4 (10.8%) .084 0.257 3 (4.1%) 3 (10.7%) .192 0.217
Middle school (5th- 9th 
grade)
23 (10.8%) 11 (17.2%) 12 (32.4%) 14 (19.2%) 9 (32.1%)
High school (10th- 12th 
grade)
38 (37.3%) 26 (40.6%) 12 (32.4%) 28 (38.4%) 10 (35.7%)
College/Postgraduate 34 (33.3%) 25 (39.1%) 9 (35.3%) 28 (38.4%) 6 (21.4%)
Marital status: married/
cohabiting




65 (63.7%) 51 (79.7%) 14 (38.9%) <.001 0.411 55 (75.3%) 10 (37.0%) <.001 0.357
Unemployed/Retired/
Med. leave
35 (34.3%) 13 (20.3%) 22 (61.1%) 18 (24.7%) 17 (63.0%)
Due to Haemophiliaa 19 (54.3%) 6 (46.2%) 13 (68.4%) .208 0.223 8 (44.4%) 11 (78.6%) .051 0.345
Physical activity practice: 
Yes
65 (63.7%) 46 (70.0%) 19 (51.4%) .038 0.206 54 (73%) 11 (39.3%) .001 0.324
Clinical measures:
Haemophilia type: HA 85 (83.3%) 50 (76.9%) 35 (94.6%) .021 0.228 59 (79.7%) 26 (92.9%) .112 0.157
Haemophilia severity
Mild (5%- 40% FVIII/
FIX)
13 (12.7%) 10 (15.4%) 3 (8.1%) .338 0.146 13 (17.6%) 0 .019 0.279
Moderate (1%- 5% 
FVIII/FIX)
32 (31.4%) 22 (33.8%) 10 (27.0%) 25 (33.8%) 7 (25.0%)
Severe (<1% FVIII/
FIX)
57 (55.9%) 33 (50.8%) 24 (64.9%) 36 (48.6%) 21 (75.0%)
Prophylaxis treatment: 
Yes
33 (32.4%) 22 (34.4%) 11 (29.7%) .632 0.048 24 (32.9%) 9 (32.1%) .944 0.007
Urgent hospital visitsb,d: 
Yes
51 (50.0%) 25 (42.4%) 26 (72.2%) .005 0.290 31 (45.6%) 20 (74.1%) .012 0.258
Hospitalizationb,d: Yes 11 (10.8%) 5 (7.7%) 6 (16.2%) .182 0.132 6 (8.1%) 5 (17.9%) .157 0.140
Bleeding episodesd: Yes 71 (69.6%) 41 (69.5%) 30 (90.9%) .019 0.245 46 (62.2%) 25 (89.3%) .006 0.284
Number of bleeding 
episodes
9 (1- 84) 9 (1- 50) 9 (1- 84) .222 0.144 6.5 (1- 50) 15 (2- 84) .032 0.254
Joint deterioration: Yes 86 (84.3%) 52 (81.3%) 34 (94.4%) .068 0.183 58 (80.6%) 28 (100%) .012 0.252
Number of affected 
jointsc
4 (1- 10) 3 (1- 10) 5 (2- 10) <.001 0.386 3 (1- 10) 5 (1- 10) .008 0.284
Comorbidities: HIV 14 (13.9%) 7 (10.9%) 7 (18.9%) .263 0.111 7 (9.6%) 7 (25.0%) .045 0.200
Comorbidities: Hepatitis 
C
23 (22.8%) 12 (18.8%) 11 (29.7%) .205 0.126 14 (19.2%) 9 (32.1%) .164 0.138
Comorbidities: Otherse 39 (38.6%) 24 (37.5%) 15 (40.5%) .762 0.030 27 (37.0%) 12 (42.9%) .587 0.054
Pain due to haemophilia
In the previous year 80 (79.2%) 45 (69.2%) 35 (94.6%) .004 0.288 52 (71.2%) 28 (100%) .001 0.317
Lasting over 3 months 63 (62.4%) 36 (56.3%) 27 (73.0%) .095 0.166 41 (56.2%) 22 (78.6%) .037 0.207
(Continues)
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for the purpose of specific studies.34-36 The results of this investiga-
tion advance the knowledge on factors associated with anxiety and 
depression among PWH, drawing relevant conclusions to inform 
interventions aiming to promote well- being among these patients.
4.1 | Professional status
The impact of haemophilia on professional activity has been widely 
demonstrated, with PWH reporting higher rates of unemployment 
and occupational disability than healthy controls.37,38 In this study, 
the association between professional status and both anxiety and 
depression remained significant even after controlling for clinical 
variables (disease severity and number of affected joints), showing 
that unoccupied patients (unemployed, retired or on medical leave) 
present higher symptomatology. These findings add to previous 
conclusions regarding PWH,7,8 providing a research direction on 
the impact of haemophilia on emotional well- being and underscor-
ing the relevance of a biopsychosocial model of haemophilia care 
that also considers professional status as a potential risk factor for 
poor mental health. Although further research is warranted, it can be 
suggested that PWH would benefit from more flexible employment 
policies. These could account for work absences due to haemophilia- 








PROMIS < 8 
(N = 65)
PROMIS ≥8 
(N = 37) P
Effect 
size*
PROMIS < 8 
(N = 74)
PROMIS ≥ 8 
(N = 28) P
Effect 
size*
More than once a 
week
41 (40.6%) 20 (30.8%) 21 (56.8%) .012 0.250 24 (32.9%) 17 (60.7%) .011 0.254
Pain durationd 
(months)
96 (1- 612) 96 (1- 528) 96 (1- 612) .788 0.034 96 (1- 612) 1 (1- 420) .915 0.013
Pain intensityd 3.3 (0- 9.6) 1.8 (0- 8) 5 (0- 9.6) <.001 0.423 2 (0- 8) 5.8 (0- 9.6) <.001 0.476
Pain interferenced 3.3 (0- 9.9) 1.6 (0- 8.4) 5.3 (0- 9.9) <.001 0.472 1.7 (0- 8.4) 5.57 (0- 9.9) <.001 0.457
Psychosocial measures:
PROMIS: Anxiety 7 (4- 19) 5 (4- 7) 10 (8- 19) - - 5 (4- 12) 10 (5- 19) <.001 0.640
PROMIS: Depression 4 (4- 20) 4 (4- 10) 9 (4- 20) <.001 0.643 4 (4- 7) 10 (8- 20) - - 
IPQ- R: Timeline acute/
chronic
13 (7- 15) 14 (7- 15) 13 (8- 15) .594 0.052 13.2 (7- 15) 13 (8- 15) .972 0.003
IPQ- R: Timeline cyclical 9 (3- 15) 9 (3- 14) 11 (3- 15) .001 0.351 9 (3- 14) 11 (8- 15) <.001 0.380
IPQ- R: Consequences 9 (3- 15) 7 (3- 15) 11 (3- 15) <.001 0.479 8 (3- 15) 12 (7- 15) <.001 0.588
IPQ- R: Personal control 8 (3- 15) 7.3 (3- 11) 8 (3- 15) .232 0.118 8 (3- 11) 8 (3- 15) .734 0.034
IPQ- R: Treatment 
control
7 (3- 12) 6 (3- 12) 7 (3- 12) .401 0.083 6 (3- 12) 7 (3- 12) .232 0.118
IPQ- R: Illness 
coherence
5.5 (3- 15) 5 (3- 15) 6 (3- 14) .146 0.144 5 (3- 15) 6 (3- 14) .031 0.214
IPQ- R: Emotional 
representation
6 (3- 15) 5 (3- 15) 7 (3- 15) <.001 0.370 5 (3- 15) 9 (3- 15) <.001 0.410




53.33 (5- 100) <.001 0.443 76.79 
(22- 100)
45.48 (5- 88) <.001 0.443
A36 Hemofilia- QoL: 
Quality of life
55 (5- 100) 65 (15- 100) 35 (5- 80) <.001 0.503 65 (15- 100) 35 (5- 80) <.001 0.408
Continuous variables are presented as median (range) and categorical variables are presented as n (%); A36 Hemofilia- QoL scores are presented as 
percentile; Bold=variables showing statistical significance at p≤0.001	and	at	least	a	medium	effect	size	(>0.30).
PROMIS–Patient- Reported Outcomes Measurement Information System; IPQ- R–Illness Perception Questionnaire- Revised; HAL–Haemophilia 
Activities List.
aSample of participants reporting being unemployed, retired or on medical leave.
bEvents that occurred due to haemophilia.
cNumber of joints pointed to be affected by haemophilia.
dData reporting to the previous year.
eMost commonly reported comorbidities were Hypertension (N = 17), Dyslipidaemias (N = 12) and Diabetes Type 2 (N = 9).
*r score for continuous variables and Pearson’s phi (Φ) coefficient for nominal variables. To interpret the meaning of the r score, Cohen’s guidelines27 
were used: a score above 0.50 is usually considered a large effect, between 0.50 and 0.30 a medium effect and between 0.30 and 0.10 a small effect 
size. The interpretation of Pearson’s phi (Φ) coefficient is analogous to the r score, expressing the strength of association between two variables.
TABLE  1  (Continued)
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4.2 | Physical activity
The beneficial effects of physical activity on physical indicators 
of PWH is well documented, namely in promoting better physi-
cal function and endurance, improving bone metabolism and 
joint range of motion, increasing muscle strength and factor 
activity.39-42
On the other hand, few studies have examined the impact of 
physical activity on psychosocial dimensions, albeit social and emo-
tional benefits of physical activity are frequently suggested for 
TABLE  2 Multivariate hierarchical logistic regression analyses for factors associated with the presence of anxiety and depressive 
symptoms among PWH
Models (Final Models)
PROMIS ≥ 8–anxiety symptoms PROMIS ≥ 8–depression symptoms
Wald OR (95% CI) P value Wald OR (95% CI) P value
Model 1 (Professional status)
Age 0.110 0.993 (0.953- 1.035) .740 0.300 1.012 (0.969- 1.057) .584
Education 1.774 0.791 (0.561- 1.117) .183 1.429 0.810 (0.574- 1.144) .232
Haemophilia severity 0.059 0.898 (0.374- 2.153) .809 3.736 2.601 (0.987- 6.857) .053
Nº of affected joints 6.005 1.326 (1.058-1.663) .014 2.005 1.160 (0.945- 1.425) .157
Professional statusa 8.282 4.646 (1.632-13.226) .004 4.773 3.333 (1.132-9.817) .029
Model 2 (Physical activity)
Age 0.100 1.006 (0.967- 1.048) .752 0.254 1.012 (0.967- 1.059) .614
Education 3.509 0.734 (0.531- 1.014) .061 2.421 0.758 (0.534- 1.075) .120
Haemophilia severity 0.015 0.949 (0.414- 2.172) .901 3.250 2.493 (0.923 - 6.732) .071
Nº of affected joints 7.418 1.353 (1.088-1.682) .006 2.982 1.208 (0.975 - 1.496) .084
Physical activityb 0.478 0.705 (0.262- 1.896) .489 5.068 0.302 (0.106-0.856) .024
Model 3 (Pain)
Age 0.142 1.009 (0.965- 1.054) .706 0.945 1.024 (0.976- 1.075) .331
Education 2.986 0.726 (0.505- 1.044) .084 2.047 0.753 (0.511- 1.111) .152
Haemophilia severity 0.131 0.841 (0.330- 2.145) .717 2.769 2.459 (0.852- 7.093) .096
No of affected joints 2.179 1.198 (0.942- 1.523) .140 0.236 1.058 (0.843- 1.329) .627
Pain intensityc 1.568 1.177 (0.912- 1.519) .211 3.232 1.293 (0.977- 1.710) .072
Pain interferencec 6.536 1.397 (1.081-1.806) .011 4.336 1.347 (1.018-1.783) .037
Model 4 (Illness perceptions)
Age 0.169 1.009 (0.967- 1.053) .681 0.599 1.021 (0.969- 1.075) .439
Education 2.221 0.768 (0.543- 1.087) .136 0.776 0.829 (0.546- 1.258) .378
Haemophilia severity 0.046 0.911 (0.387- 2.144) .831 2.631 2.774 (0.808- 9.516) .105
No of affected joints 1.450 1.162 (0.910- 1.482) .228 0.168 0.941 (0.703- 1.259) .682
Timeline cyclicald 1.056 1.137 (0.890- 1.452) .304 0.493 1.114 (0.825- 1.504) .482
Consequencesd 2.060 1.231 (0.927- 1.634) .151 6.336 1.600 (1.110-2.308) .012
Emotional 
representationd
0.720 1.095 (0.887- 1.352) .396 0.894 1.113 (0.880- 1.408) .373
MODEL 1: Anxiety: χ2(5) = 28.282 P < .001, Nagelkerke R
2 = 0.342, Final model correctly predicted 74.7% of all participants; Depression: χ2(5) = 24.005 
P < .001, Nagelkerke R2 = 0.312, Final model correctly predicted 80.8% of all participants.
Model 2: Anxiety: χ2(5) = 21.833 P = .001, Nagelkerke R
2 = 0.269, Final model correctly predicted 74.0% of all participants; Depression: χ2(5) = 26.462 
P < .001, Nagelkerke R2 = 0.335, Final model correctly predicted 78.0% of all participants.
Model 3: Anxiety: χ2(6) = 39.982 P < .001, Nagelkerke R
2 = 0.452, Final model correctly predicted 78.0% of all participants; Depression: χ2(6) = 39.346 
P < .001, Nagelkerke R2 = 0.468, Final model correctly predicted 80.0% of all participants.
Model 4: ANXIETY: χ2(7) = 33.237 P < .001, Nagelkerke R
2 = 0.388, Final model correctly predicted 78.0% of all participants; DEPRESSION: χ2(7) = 45.195 
P < .001, Nagelkerke R2 = 0.524, Final model correctly predicted 84.0% of all participants.
CI, Confidence Interval.
aDichotomic variable: Active (Full/Part- time/Student) vs Unemployed/Retired/Med. leave.
bDichotomic variable: no physical exercise practice vs occasional or regular practice of physical exercise.
cContinuous variable measured through a 0- 10 NRS (Numerical Rating Scale).
dContinuous variable, subscale of IPQ- R: Illness Perception Questionnaire.
Bold=significant variables at p≤	.05
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PWH.1,43 This fact is supported by present results, since PWH prac-
ticing physical activity had lower depressive symptoms, in agree-
ment with previous findings.44 Therefore, exploring the effects of 
physical activity figures as a promising area of research in terms of 
promoting psychological health among PWH, similarly to what has 
been described in other chronic illness.45,46 Ultimately, the efficacy 
of specific interventions for promoting physical activity, such as 
cognitive- behavioural strategies, behavioural activation or motiva-
tion interviewing should be analysed, as well as its effects on psy-
chological symptoms of PWH.
4.3 | Pain
Pain is a central issue in haemophilia care, either due to haemar-
throsis or to chronic arthropathy,47 which has been associated with 
higher emotional distress.8,33 Congruently in this study, participants 
with significant anxiety/depression symptoms were more likely to 
report higher pain frequency, with heightened intensity and interfer-
ence. However, pain interference was the only dimension retaining 
significance in the regression models, being associated with anxiety 
and depression even after controlling for demographic and clinical 
variables. These findings highlight the relevance of implementing ef-
fective pain control strategies and reinforce the recent calls to action 
on the need to develop specific treatment guidelines for haemophilia 
pain management.48 These also underline the important role of well- 
prepared multidisciplinary teams for haemophilia care,1 skilled to de-
liver adequate and coordinated (non)pharmacological interventions 
for optimum pain management. Based on current results, it can be 
hypothesized that interventions aiming to decrease the perception 
of pain interference would be particularly helpful in reducing psycho-
logical distress symptoms. In this scope, psychological interventions 
are effective in fostering adaptive pain coping strategies, namely 
through specific cognitive techniques, such as cognitive restructur-
ing, aiming to decrease pain intensity and perception of interfer-
ence.49 This corroborates previous findings among PWH, wherein 
the association between pain cognitions and emotional well- being 
is emphasized, namely the effect of pain reinterpreting techniques 
in pain management.47,50,51 Other strategies, such as relaxation, 
hypnosis and imagery training have been related to improved pain 
reports and reduced analgesic intake in former studies conducted 
among PWH.52,53 Surprisingly, and despite their reported success, 
there is a scarcity of recent investigations focusing on psychologi-
cal interventions for pain in PWH and, consequently, an important 
knowledge- gap on the potential effectiveness of such interventions.
4.4 | Illness perceptions
In face of a chronic illness, people develop individual representations 
of that disease, which have been shown to influence several health- 
related outcomes.54,55 The results from this study corroborate these 
findings, showing that patients with anxiety and depression had 
more threatening illness representations. This translates into a higher 
perception of symptoms unpredictability (“duration cyclical”) and of 
negative consequences associated with the disease (“consequences”), 
as well as more negative feelings in face of haemophilia (“emotional 
representation”). In the multivariate analysis, a significant asso-
ciation was yielded between a negative perception of haemophilia- 
related consequences and depressive symptomatology, above and 
beyond clinical factors. This finding shows that depressed patients 
are likely to perceive haemophilia as having a more negative impact 
on their lives than those without significant depressive symptoms. 
In line with these findings, perception of consequences has indeed 
been consistently associated with psychological distress in a variety 
of diseases.56,57 In the haemophilia field, the relevance of patients’ 
individual perceptions has also been emphasized, with the perceived 
impact of the disease having a strong effect on clinical and psychoso-
cial outcomes.58
These conclusions have relevant implications for haemophilia care 
planning, since it seems that promoting more adaptive illness percep-
tions may be an important strategy to prevent or decrease psychological 
distress. Namely, this could be achieved by diminishing the perception 
of negative impact of the disease, for example through psychoeduca-
tion, cognitive therapy or third- wave psychological interventions.
Despite the vast literature examining illness perceptions, stud-
ies in haemophilia field have only focused on their association with 
treatment adherence, namely on their influence in the adherence to 
clotting factor therapy.59-61 Illness perceptions are therefore emerg-
ing as important variables to consider in haemophilia, with the re-
sults from this study reinforcing the need to expand the focus of 
research in this field.
4.5 | Limitations
This is a cross- sectional study and, therefore, temporal relations 
among findings, namely cause- effect associations, should not be 
established. Moreover, the classification of participants accord-
ing to significant anxiety and depression symptoms was based on a 
self- report measure and not on formal clinical assessment of symp-
toms. Also, the sample size of the groups (with or without anxiety/
depression) is unbalanced, preventing from the use of more accu-
rate statistical procedures. Future research with larger sample sizes 
and longitudinal assessment of outcomes would help in establishing 
more definite conclusions. Finally, it would be of interest to com-
pare anxious/depressed patients in terms of objectively measured 
outcomes, such as a clinical/radiological assessment of joint status.
5  | CONCLUSION
Socio- demographic (eg age, gender) and disease- related (eg sever-
ity) characteristics have been associated with increased psychologi-
cal symptoms in chronic pain patients, thus emerging as potential 
risk factors for higher emotional distress.62 However, the identifi-
cation of these characteristics is of limited value for clinical inter-
vention, due to their unchangeable nature. By identifying a specific 
set of modifiable variables that were associated with anxiety and 
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depression, this study provided an evidence base for the develop-
ment of preventive risk- targeted interventions aimed to foster emo-
tional well- being, which might even contribute to the improvement 
of disease- related outcomes among PWH.
Although more research is needed to clearly identify specific risk 
factors for increased distress in PWH, it is clear that patients could 
substantially benefit from a complete multidisciplinary assessment, 
including an emotional distress screening that could identify spe-
cific needs and inform the development of appropriate treatment 
plans.1,8 Given the specific challenges of haemophilia across the 
lifespan, it is important to acknowledge them in adulthood and older 
age, and build on that knowledge to develop and test the effective-
ness of specific psychological interventions.63
In sum, this study sheds light on factors that could be targeted 
to promote well- being and adaptation among PWH. Psychological 
interventions are an effective strategy for this purpose, which effec-
tiveness should be tested in the haemophilia field.
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